MapLight Therapeutics, Inc
Filings
Newest firstThe annual , the quarterly and the filed between them when something material happens.
- Sep 23424B3Prospectus for an offering
- Sep 9S-1Registration of new shares
- Aug 2013GPassive stake of 5% or more (13G), filed by Pivotal bioVenture Partners Fund II
- Aug 1310-QQuarterly report
- Aug 138-KMaterial agreement and results of operations1.012.023.027.019.01
- Jul 278-KRegulation FD disclosure and other events7.018.019.01
- Jun 248-KShareholder vote5.07
- Jun 228-KRegulation FD disclosure and other events7.018.019.01
- Jun 188-KOfficer or director change5.02
- May 1410-QQuarterly report
- May 148-KResults of operations and Regulation FD disclosure2.027.019.01
- Apr 298-KOfficer or director change5.02
- Mar 2610-KAnnual report
- Mar 268-KResults of operations and Regulation FD disclosure2.027.019.01
- Jan 98-KResults of operations and Regulation FD disclosure2.027.019.01
- Dec 4, 202510-QQuarterly report
- Dec 4, 20258-KResults of operations and Regulation FD disclosure2.027.019.01
- Oct 29, 20258-KUnregistered sale of shares and bylaws or fiscal year changed3.025.038.019.01
- Oct 27, 2025424B3Prospectus for an offering
- Sep 19, 2025S-1Registration of new shares